Tamara Maes
8Patents
1h-index
23Co-inventors
47Inventor score
Filing activity: Jul 18, 2005 → Dec 16, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9908859B2 | Lysine demethylase inhibitors for myeloproliferative disorders | Chemistry; Metallurgy | 5 | Active |
| US10265279B2 | Combinations of LSD1 inhibitors for use in the treatment of solid tumors | Human Necessities | 1 | Active |
| US10780081B2 | Method of treating multiple sclerosis employing a LSD1-inhibitor | Human Necessities | 1 | Active |
| US11034991B2 | Methods to determine KDM1A target engagement and chemoprobes useful therefor | Physics | 1 | Active |
| US9046522B2 | Markers for endometrial cancer | Physics | 0 | Active |
| US12195783B2 | Methods to determine KDM1A target engagement and chemoprobes useful therefor | Physics | 0 | Active |
| US7745127B2 | Molecular diagnostic method for dementia with lewy bodies | Physics | 0 | Active |
| US11013698B2 | Combinations of LSD1 inhibitors for the treatment of hematological malignancies | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.